Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/143718
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Alzheimer's disease (AD) represents a global burden in the economics of healthcare systems. Amyloid-β (Aβ) peptides are formed by amyloid-β precursor protein (AβPP) cleavage, which can be processed by two pathways. The cleavage by the α-secretase A Disintegrin And Metalloprotease 10 (ADAM10) releases the soluble portion (sAβPPα) and prevents senile plaques. This pathway remains largely unknown and ignored, mainly regarding pharmacological approaches that may act via different signaling cascades and thus stimulate non-amyloidogenic cleavage through ADAM10. This review emphasizes the effects of natural compounds on ADAM10 modulation, which eventuates in a neuroprotective mechanism. Moreover, ADAM10 as an AD biomarker is revised. New treatments and preventive interventions targeting ADAM10 regulation for AD are necessary, considering the wide variety of ADAM10 substrates.
Matèries
Matèries (anglès)
Citació
Citació
MANZINE, Patricia, ETTCHETO ARRIOLA, Miren, CANO FERNÁNDEZ, Amanda, BUSQUETS FIGUERAS, Oriol, MARCELLO, Elena, PELUCCHI, Silvia, DI LUCA, Monica, ENDRES, Kristina, OLLOQUEQUI, Jordi, CAMINS ESPUNY, Antoni, COMINETTI, Márcia regina. ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker. _Biomedicine & Pharmacotherapy_. 2019. [consulta: 20 de gener de 2026]. ISSN: 0753-3322. [Disponible a: https://hdl.handle.net/2445/143718]